Real-Time Monitoring of Nuclear Factor κB Activity in Cultured Cells and in Animal Models
暂无分享,去创建一个
T. Wurdinger | B. Tannous | D. Noske | C. Badr | Lee-Ann Tjon-Kon-Fat | Christian E. Badr | J. M. Niers
[1] P. Massion,et al. IkappaB kinase-alpha regulates endothelial cell motility and tumor angiogenesis. , 2008, Cancer research.
[2] R. Guo,et al. Increased staining for phosphorylated AKT and nuclear factor‐κB p65 and their relationship with prognosis in epithelial ovarian cancer , 2008, Pathology international.
[3] R. Weissleder,et al. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. , 2008, Cancer cell.
[4] P. Korkolopoulou,et al. Expression of nuclear factor-kappaB in human astrocytomas: relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival. , 2008, Human pathology.
[5] S. Ghosh,et al. Shared Principles in NF-κB Signaling , 2008, Cell.
[6] Ralph Weissleder,et al. A secreted luciferase for ex vivo monitoring of in vivo processes , 2008, Nature Methods.
[7] Howard E. Gendelman,et al. Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease , 2007, Proceedings of the National Academy of Sciences.
[8] R. Svensson,et al. Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy. , 2007, Cancer research.
[9] B. Bejcek,et al. NF-κB controls growth of glioblastomas/astrocytomas , 2007, Molecular and Cellular Biochemistry.
[10] X. Breakefield,et al. A Highly Sensitive Assay for Monitoring the Secretory Pathway and ER Stress , 2007, PloS one.
[11] C. Gondi,et al. Transfection with Anti-p65 Intrabody Suppresses Invasion and Angiogenesis in Glioma Cells by Blocking Nuclear Factor-κB Transcriptional Activity , 2007, Clinical Cancer Research.
[12] M. García-Carrasco,et al. The transcription factor nuclear factor-kappa B and cancer. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).
[13] R. Martuza,et al. Treatment of Implantable NF2 Schwannoma Tumor Models with Oncolytic Herpes Simplex Virus G47Δ , 2007, Cancer Gene Therapy.
[14] N. Sun,et al. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer. , 2006, The Annals of thoracic surgery.
[15] M. Karin. Nuclear factor-κB in cancer development and progression , 2006, Nature.
[16] K. F. Perry,et al. Metabolic biotinylation of cell surface receptors for in vivo imaging , 2006, Nature Methods.
[17] S. Ghosh,et al. Role of nuclear factor‐κB in the immune system and bone , 2005 .
[18] Michael Karin,et al. NF-κB: linking inflammation and immunity to cancer development and progression , 2005, Nature Reviews Immunology.
[19] David Piwnica-Worms,et al. Real-time imaging of ligand-induced IKK activation in intact cells and in living mice , 2005, Nature Methods.
[20] H. Duan,et al. Histone Deacetylase Inhibitors Down-Regulate bcl-2 Expression and Induce Apoptosis in t(14;18) Lymphomas , 2005, Molecular and Cellular Biology.
[21] R. Weissleder,et al. Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[22] T. Crombleholme,et al. Optimized large-scale production of high titer lentivirus vector pseudotypes. , 2004, Journal of virological methods.
[23] D. Brenner,et al. In Vivo Pattern of Lipopolysaccharide and Anti-CD3-Induced NF-κB Activation Using a Novel Gene-Targeted Enhanced GFP Reporter Gene Mouse1 , 2004, The Journal of Immunology.
[24] Pingfu Fu,et al. Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. , 2004, Neoplasia.
[25] S. Shukla,et al. Suppression of Constitutive and Tumor Necrosis Factor α-Induced Nuclear Factor (NF)-κB Activation and Induction of Apoptosis by Apigenin in Human Prostate Carcinoma PC-3 Cells: Correlation with Down-Regulation of NF-κB-Responsive Genes , 2004, Clinical Cancer Research.
[26] M. Eren,et al. Tumor Necrosis Factor α Activates the Human Plasminogen Activator Inhibitor-1 Gene through a Distal Nuclear Factor κB Site* , 2004, Journal of Biological Chemistry.
[27] Mark A Rizzo,et al. An improved cyan fluorescent protein variant useful for FRET , 2004, Nature Biotechnology.
[28] F. Meyskens,et al. Comparative expression of NFkappaB proteins in melanocytes of normal skin vs. benign intradermal naevus and human metastatic melanoma biopsies. , 2004, Pigment cell research.
[29] Marianne Fillet,et al. NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells , 2003, Oncogene.
[30] L. Coussens,et al. Inflammation and cancer , 2002, Nature.
[31] H. Ishii,et al. Bleomycin induces E-selectin expression in cultured umbilical vein endothelial cells by increasing its mRNA levels through activation of NF-kappaB/Rel. , 2002, Toxicology and applied pharmacology.
[32] David S. Park,et al. Constitutive Nuclear Factor-κB Activity Is Required for Central Neuron Survival , 2002, The Journal of Neuroscience.
[33] Xiankui Li,et al. Establishment and characterization of a schwannoma cell line from a patient with neurofibromatosis 2. , 2002, International journal of oncology.
[34] H. Carlsen,et al. In Vivo Imaging of NF-κB Activity1 , 2002, The Journal of Immunology.
[35] C. Bucana,et al. Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis , 2001, Oncogene.
[36] H. Kalthoff,et al. Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin , 2001, Oncogene.
[37] R. Schmid,et al. Suppression of NF-κB activity by sulfasalazine is mediated by direct inhibition of IκB kinases α and β , 2000 .
[38] B. Rayet,et al. Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.
[39] H. Pahl. Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.
[40] B. Aggarwal,et al. VEGI, a new member of the TNF family activates Nuclear Factor-κB and c-Jun N-terminal kinase and modulates cell growth , 1999, Oncogene.
[41] M. Neurath,et al. Role of NF-κB in immune and inflammatory responses in the gut , 1998 .
[42] C. Brinckerhoff,et al. Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1beta-stimulated synovial fibroblasts. , 1998, Arthritis and rheumatism.
[43] M. Odeh,et al. Role of cytokines in rheumatoid arthritis. , 1998, Drug news & perspectives.
[44] I. Adcock,et al. Transcription factors and asthma. , 1998, The European respiratory journal.
[45] R. Schmid,et al. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. , 1998, The Journal of clinical investigation.
[46] A. Palotie,et al. Genomic Organization of Human and Mouse Genes for Vascular Endothelial Growth Factor C* , 1997, The Journal of Biological Chemistry.
[47] A. Israël,et al. NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity. , 1996, Development.
[48] E M Schwarz,et al. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. , 1995, Genes & development.
[49] H. Volk,et al. Stimulation of the Human Cytomegalovirus IE Enhancer/Promoter in HL-60 Cells by TNFα Is Mediated via Induction of NF-κB , 1995 .
[50] H. Vinters,et al. Unexpected Expression of Intermediate Filament Protein Genes in Human Oligodendroglioma Cell Lines , 1995, Journal of neuropathology and experimental neurology.
[51] G. Felsenfeld,et al. A 5′ element of the chicken β-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila , 1993, Cell.
[52] R. Weichselbaum,et al. Ionizing radiation induces expression and binding activity of the nuclear factor kappa B. , 1991, The Journal of clinical investigation.
[53] G. Nabel,et al. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[54] David Baltimore,et al. Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.
[55] Y. Song,et al. NF-kappaB as a potential molecular target for cancer therapy. , 2007, BioFactors.
[56] Y. Song,et al. NF‐κB as a potential molecular target for cancer therapy , 2007 .
[57] M. Karin. Nuclear factor-kappaB in cancer development and progression. , 2006, Nature.
[58] T. Blackwell,et al. Bioluminescence imaging. , 2005, Proceedings of the American Thoracic Society.
[59] S. Shukla,et al. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.
[60] X. Breakefield,et al. Improved HSV-1 amplicon packaging system using ICP27-deleted, oversized HSV-1 BAC DNA. , 2003, Methods in molecular medicine.
[61] David S. Park,et al. Constitutive nuclear factor-kappa B activity is required for central neuron survival. , 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[62] Rune Blomhoff,et al. In vivo imaging of NF-kappa B activity. , 2002, Journal of immunology.
[63] R. Schmid,et al. Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. , 2000, Gastroenterology.
[64] H. Pahl,et al. Activators and target genes of Rel/NF-kappaB transcription factors. , 1999, Oncogene.
[65] M J May,et al. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.
[66] K. Schulze-Osthoff,et al. Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta. , 1998, The Journal of biological chemistry.
[67] M. Feldmann,et al. Role of cytokines in rheumatoid arthritis. , 1996, Annual review of immunology.
[68] H. Volk,et al. Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB. , 1995, Virology.
[69] G. Nabel,et al. An inducible transcription factor activates expression of human immunodeficiency virus in T cells , 1990, Nature.